Font size
Professor Alessandro Prigione

 

CureMILS


CureMILS - A reprogramming-based strategy for drug repositioning in patients with mitochondrial DNA-associated Leigh syndrome

This exciting research project aims to develop therapies for mitochondrial DNA-associated Leigh syndrome (MILS).

IMP is a partner in the project, which is part of the European Joint Programme on Rare Diseases.

Watch Professor Alessandro Prigione provide an update on the CureMILS project.

Read more about the project.

 

© 2022 Int. Mito Patients